Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy

SIMPLE SUMMARY: Enhanced glycolysis is a major feature of cancer glycometabolism, and SLC2A1 is one of the pivotal genes in cancer glycometabolism. Although SLC2A1 plays an important role in the growth of many cancers, pan-cancer analysis allows us to more comprehensively and systematically understa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Haosheng, Long, Guojie, Zheng, Yuzhen, Yang, Xingping, Cai, Weijie, He, Shiyun, Qin, Xianyu, Liao, Hongying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657346/
https://www.ncbi.nlm.nih.gov/pubmed/36358765
http://dx.doi.org/10.3390/cancers14215344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657346/
https://www.ncbi.nlm.nih.gov/pubmed/36358765
http://dx.doi.org/10.3390/cancers14215344

Ejemplares similares